Pancreatic Cancer Research

ResearcherHeidelberg UniversityNo recent work listed

Prince Saforo Amponsah

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5891-5823; OpenAlex author ID A5091506050. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper

Papers 2

  1. microRNA-210 overexpression inhibits tumor growth and potentially reverses gemcitabine resistance in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2016.11.035↗
  2. MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2016.01.038↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nathalie Bauer · 2 shared papers, 2016–2017 · strength 0.13
  2. Pei Fan · 2 shared papers, 2016–2017 · strength 0.13
  3. Ingrid Herr · 2 shared papers, 2016–2017 · strength 0.13
  4. Clifford C. Nwaeburu · 1 shared paper, 2016 · strength 0.05
  5. Alia Abukiwan · 1 shared paper, 2016 · strength 0.05
  6. Yefeng Yin · 1 shared paper, 2016 · strength 0.05
  7. Peter Schemmer · 1 shared paper, 2016 · strength 0.05
  8. Xi Xiao · 1 shared paper, 2016 · strength 0.05
  9. Li Liu · 1 shared paper, 2016 · strength 0.05
  10. Yiyao Zhang · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.